Source link : https://www.newshealth.biz/health-news/dont-try-arbs-for-severe-covid-trial-indicates/
The angiotensin receptor blocker (ARB) losartan led to hypotension and failed to improve mortality in patients hospitalized for acute COVID-19, according to the randomized, prospective — and prematurely terminated — ARBs CORONA II trial. Among 341 patients in Canada and France hospitalized for acute COVID-19, 39.8% of patients who were prescribed losartan developed serious adverse […]
Author : News Health
Publish date : 2024-07-12 18:02:42
Copyright for syndicated content belongs to the linked Source.
inHealth